Cochrane Abstracts
Non‐vitamin K antagonist oral anticoagulants (NOACs) after transcatheter aortic valve replacement (TAVR): a network meta‐analysis
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Non‐vitamin K Antagonist Oral Anticoagulants (NOACs) After Transcatheter Aortic Valve Replacement (TAVR): a Network Meta‐analysis." Cochrane Abstracts, John Wiley & Sons, Inc, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/440732/all/Non‐vitamin_K_antagonist_oral_anticoagulants__NOACs__after_transcatheter_aortic_valve_replacement__TAVR_:_a_network_meta‐analysis.
Non‐vitamin K antagonist oral anticoagulants (NOACs) after transcatheter aortic valve replacement (TAVR): a network meta‐analysis. Cochrane Abstracts. John Wiley & Sons, Inc; 2025. https://evidence.unboundmedicine.com/evidence/view/Cochrane/440732/all/Non‐vitamin_K_antagonist_oral_anticoagulants__NOACs__after_transcatheter_aortic_valve_replacement__TAVR_:_a_network_meta‐analysis. Accessed April 26, 2025.
Non‐vitamin K antagonist oral anticoagulants (NOACs) after transcatheter aortic valve replacement (TAVR): a network meta‐analysis. (2025). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/440732/all/Non‐vitamin_K_antagonist_oral_anticoagulants__NOACs__after_transcatheter_aortic_valve_replacement__TAVR_:_a_network_meta‐analysis
Non‐vitamin K Antagonist Oral Anticoagulants (NOACs) After Transcatheter Aortic Valve Replacement (TAVR): a Network Meta‐analysis [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2025. [cited 2025 April 26]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/440732/all/Non‐vitamin_K_antagonist_oral_anticoagulants__NOACs__after_transcatheter_aortic_valve_replacement__TAVR_:_a_network_meta‐analysis.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Non‐vitamin K antagonist oral anticoagulants (NOACs) after transcatheter aortic valve replacement (TAVR): a network meta‐analysis
ID - 440732
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/440732/all/Non‐vitamin_K_antagonist_oral_anticoagulants__NOACs__after_transcatheter_aortic_valve_replacement__TAVR_:_a_network_meta‐analysis
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
